Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

Open-label trial demonstrates efficacy of gabapentin monotherapy in AIDS-related neuropathy

April 29, 1999

Merck's Maxalt proves effective in women with menstrual migraine

April 29, 1999

Triazine-based adenosine antagonists in development at Boehringer Ingelheim

April 29, 1999

Sibia identifies novel mGluR5-selective compounds

April 29, 1999

New CRF antagonists described by DuPont for stress-related disorders

April 29, 1999

Continuing focus on PARP inhibitors at Guilford

April 29, 1999

Cypros given notice of allowance on U.S. patent for NCCBs

April 29, 1999

Safety and efficacy of riluzole examined in pilot study in early, untreated PD

April 28, 1999

Guilford's new PARP inhibitors potentially useful for wide variety of disorders

April 28, 1999

Tryptamine analogues as potent and selective human 5-HT2A antagonists

April 28, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 13, 2026.
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...
Muscarinic M4 receptor positive allosteric modulators described in Neurosterix patent
BioWorld Science
Neurosterix Pharma Sarl has divulged 3-cyclopropylpyrazole derivatives acting as muscarinic M4 receptor positive allosteric modulators. They are reported to be...